Michelle A. Rudek, Pharm.D., Ph.D.

Headshot of Michelle A. Rudek
  • Director, Analytical Pharmacology Shared Resource, Sidney Kimmel Comprehensive Cancer Center
  • Professor of Oncology

Research Interests

Clinical pharmacology of anticancer agents; early phase drug development; drug tolerability in cancer patients with HIV/AIDS; drug tolerability in cancer patients with organ dysfunction; blood-brain barrier penetration of drugs. ...read more

Background

Michelle Rudek, Pharm.D., Ph.D., is a Professor of oncology at the Johns Hopkins University School of Medicine and director of the Analytical Pharmacology Core for the Johns Hopkins Kimmel Cancer Center. 

Dr. Rudek studies the pharmacokinetic-pharmacodynamic properties of anticancer agents, and her research is focused on oncology (preclinical studies and Phase I clinical trials/early phase drug development) and special populations within oncology (AIDS malignancy, and organ dysfunction). 

...read more

Titles

  • Director, Analytical Pharmacology Shared Resource, Sidney Kimmel Comprehensive Cancer Center
  • Co-Director, Pharmacology and Pharmacometrics Core, Tuberculosis Research Advancement Center
  • Co-Leader, In Vivo Pharmacokinetics and Bioanalysis Unit, Drug Discovery Development Core, Institute for Clinical and Translational Research
  • Leader, Pharmacokinetics Network Resource Laboratory, AIDS Malignancy Consortium
  • Professor of Oncology
  • Professor of Medicine

Departments / Divisions

Centers & Institutes

Education

Degrees

  • B.S.; University of Pittsburgh (Pennsylvania) (1995)
  • Ph.D.; Virginia Commonwealth University (Virginia) (2001)
  • Pharm.D.; Virginia Commonwealth University (Virginia) (2001)

Research & Publications

Research Summary

Dr. Rudek is investigating the pharmacokinetic and pharmacodynamic behavior of anticancer agents and identifying determinants that impact the PK/PD variability of these agents with the hopes of individualizing therapy.

Clinical Trials

Learn more about clinical trials at the Johns Hopkins Kimmel Cancer Center.

Contact for Research Inquiries

Email me

Patient Ratings & Comments

The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

Is this you? Edit Profile
back to top button